NVNO — enVVeno Medical Balance Sheet
0.000.00%
- $75.45m
- $32.51m
- 35
- 25
- 56
- 33
Annual balance sheet for enVVeno Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1.31 | 9.33 | 54.7 | 39 | 46.4 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0 | — | — | — | — |
Prepaid Expenses | |||||
Total Current Assets | 1.42 | 9.57 | 55 | 39.4 | 46.9 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.17 | 0.939 | 2.6 | 2.19 | 1.68 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 3.43 | 10.5 | 57.7 | 41.7 | 48.6 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.88 | 3.19 | 1.58 | 1.53 | 1.37 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.44 | 3.44 | 3.29 | 2.93 | 2.44 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 0.99 | 7.1 | 54.4 | 38.7 | 46.2 |
Total Liabilities & Shareholders' Equity | 3.43 | 10.5 | 57.7 | 41.7 | 48.6 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |